FSMEX vs. PRHSX

In the year-to-date period, FSMEX achieves a -3.41% return, which is significantly higher than PRHSX's -5.96% return. Over the past 10 years, FSMEX has outperformed PRHSX with an annualized return of 4.47%, while PRHSX has yielded a comparatively lower -0.73% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

FSMEX has a 0.68% expense ratio, which is lower than PRHSX's 0.80% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Medical Technology and Devices Portfolio (FSMEX) and T. Rowe Price Health Sciences Fund (PRHSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FSMEX Sharpe Ratio is -0.36, which is higher than the PRHSX Sharpe Ratio of -0.95. The chart below compares the historical Sharpe Ratios of FSMEX and PRHSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

FSMEX has not paid dividends to shareholders, while PRHSX's dividend yield for the trailing twelve months is around 13.70%.

The maximum FSMEX drawdown since its inception was -43.45%, smaller than the maximum PRHSX drawdown of -47.79%. Use the drawdown chart below to compare losses from any high point for FSMEX and PRHSX. For additional features, visit the drawdowns tool.

The current volatility for Fidelity Select Medical Technology and Devices Portfolio (FSMEX) is 5.51%, while T. Rowe Price Health Sciences Fund (PRHSX) has a volatility of 7.98%. This indicates that FSMEX experiences smaller price fluctuations and is considered to be less risky than PRHSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.